Target intelligence / Profile preview

tRNA (guanine(26)-N(2))-dimethyltransferase (TRMT1)

Target
TRMT1
Molecular classification
Enzyme
01

Overview

tRNA (guanine(26)-N(2))-dimethyltransferase (TRMT1) is an enzyme responsible for catalyzing the formation of N2,N2-dimethylguanosine (m(^{2,2})G) at position 26 in both cytoplasmic and mitochondrial tRNAs[4][5]. This modification supports efficient protein translation and helps maintain redox homeostasis in cells, protecting them against oxidative stress[1][4]. TRMT1 contains a C-terminal zinc finger motif critical for its function, uses S-adenosyl methionine as a methyl donor, and its deficiency or mutation results in decreased tRNA methylation, lowered protein synthesis, higher oxidative stress, and is implicated in certain forms of autosomal recessive intellectual disorder[4][5]. The enzyme is a direct human substrate for SARS-CoV-2 main protease (Mpro), which can cleave and inactivate TRMT1, further highlighting its importance in cell biology and stress responses[1][3].

Other names
tRNA methyltransferase 1hTRM1FLJ20244TRM1tRNA 2,2-dimethylguanosine-26 methyltransferasetRNA(guanine-26,N(2)-N(2)) methyltransferasetRNA(m(2,2)G26)dimethyltransferaseMRT68N(2),N(2)-dimethylguanosine tRNA methyltransferaseTRMT1 homolog
02

Biological functions

tRNA modificationProtein synthesisRedox homeostasis
03

Disease associations

Intellectual disability (autosomal recessive forms)Other (cellular stress and response to oxidative stress)
04

Safety considerations

Loss-of-function mutations may cause perturbation of protein synthesis and cellular redox balance; associated with intellectual disability
05

Biomarkers

m(^{2,2})G (N2,N2-dimethylguanosine) modification levels in tRNA (as an indirect marker of TRMT1 function)

Beyond the preview

Go deeper on tRNA (guanine(26)-N(2))-dimethyltransferase (TRMT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tRNA (guanine(26)-N(2))-dimethyltransferase (TRMT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call